What is the NOAEL for Ampelopsin?
Ampelopsin has 4 NOAEL studies in the database. The lowest reported value is KD8QND6427 UNII. Source: openFDA substances.
NOAEL Data
Cosmetic Ingredient
Ampelopsin
Also known as: Dihydromyricetin, (2R-trans)-2,3-Dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one, Flavanone, 3,3',4',5,5',7-hexahydroxy-, 3,3',4',5,5',7-Hexahydroxy-2,3-dihydroflavanonol, UNII-KD8QND6427 (+5 more)
CAS 27200-12-0
Ampelopsin (CAS 27200-12-0) is a chemical substance. Key regulatory status: 1 regulatory/inventory list, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat.
SOURCE
noael studies public
NOAEL studies
4
SOURCE
chemical inventory jurisdictions
Regulatory lists
1
SOURCE
eu clp annex vi
GHS signal
Not classified
Chemical Identity
CAS, identifiers, formula, and alternate names for the matched substance record.
SOURCE
DSSTox identifiers
16 fields
Name
Ampelopsin
CAS Number
27200-12-0
DTXSID
DTXSID50181676
Molecular Formula
C15H12O8
InChI Key
KJXSIXMJHKAJOD-LSDHHAIUSA-N
Monoisotopic Mass
320.053217
Synonyms
Dihydromyricetin(2R-trans)-2,3-Dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-oneFlavanone, 3,3',4',5,5',7-hexahydroxy-3,3',4',5,5',7-Hexahydroxy-2,3-dihydroflavanonolUNII-KD8QND6427(+)-Dihydromyricetin(2R,3R)-2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one(2R,3R)-3,3',4',5,5',7-hexahydroxy-2,3-dihydroflavanonol(2R,3R)-3,5,7,3',4',5'-hexahydroxyflavanoneAmpeloptin
Functional Uses
Industrial and product-use categories associated with this substance.
SOURCE
EPA CPDat
1 records
Softener and conditioner
Regulatory Lists
Inventory, screening, and regulatory list matches from public chemical databases.
SOURCE
EPA CPDat
1 records
| List | Keyword | Source |
|---|---|---|
| Canada; pharmaceutical | DrugBank | DrugBank |
NOAEL Studies
Toxicology endpoints rendered from public NOAEL study rows.
SOURCE
NOAEL studies
Showing 4 of 4 studies
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| KD8QND6427 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| KD8QND6427 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| KD8QND6427 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| KD8QND6427 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
Showing 4 of 4 studies
Cosmetic Safety Profile
Same-CAS cosmetic ingredient record for cross-vertical context.
SOURCE
CosIng / Ingredients DB
EU Status
permitted
Max
-
Category
Skin Conditioning
Pharmaceutical Data
Same-CAS pharmaceutical records from drug and bioactivity sources.
SOURCE
EMBL-EBI ChEMBL
AMPELOPSIN
ChEMBL Phase
2
Adverse Events
0
Bioactivity
4
Cannabis Data
Same-CAS cannabis compliance and lab records where available.
SOURCE
Cannabis regulatory / lab data
efsa substances
1 cannabis record found in efsa substances.
View full cannabis profile →Frequently Asked Questions
What regulatory lists include Ampelopsin?
Ampelopsin appears on 1 regulatory/inventory list including Canada; pharmaceutical. Source: EPA CPDat.
Is Ampelopsin used in cosmetics?
Yes, Ampelopsin is also indexed as a cosmetic ingredient under the name DIHYDROMYRICETIN. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Where does the safety data for Ampelopsin come from?
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, CosIng / Ingredients DB, ChEMBL / DailyMed, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Is Ampelopsin used outside industrial chemicals?
Ampelopsin also appears in cosmetics, pharmaceutical, cannabis databases.